Bayer CropScience Q2 FY26 Share Price & Earnings Call Analysis
- Market cap
- ₹14,785 Cr
- P/E
- 20.19
- ROE
- 23.70%
- PEG
- 38.11
- Price to sales
- 2.65
- Debt to equity
- 0.03
- 52W high / low
- ₹4,990 / ₹3,265
- Sales growth (5Y)
- 5.90%
- EBITDA margin
- 15.96%
- Net profit margin
- 12.14%
- Promoter holding
- 71.44%
- Sales (last year)
- ₹5,595 Cr
Bayer CropScience is engaged in Agri Care business which primarily includes manufacture, sale and distribution of insecticides, fungicides, herbicide and various other agrochemical products and corn seeds.[1]
Guidance scorecard · Q2 FY26 call
What Bayer Crop Sci.'s management guided
and where it ranks in Fertilizers & Agrochemicals
Fertilizers & Agrochemicals
RevenueQ2 FY26 call
0–10%- Aspirational revenue growth target is high single-digit to low double-digit over the next 3-5 years.
- Growth driven by a strong, strategic focus on Crop Protection (CP) portfolio backed by innovations and doubling of corn seeds portfolio.
- Expect steady improvement in profitability alongside revenue growth, aiming for around 100 basis points margin improvement over 2-3 years starting from FY 2024-25.
- Volume growth is important, but margins have limitations, especially in corn due to higher incremental production costs influenced by weather.
- Pricing power and competitive positioning through new product launches (e.g., BICOTA, Camalus, Xivana Smart) will support growth.
2 more points from Bayer Crop Sci.'s call on revenue
Create a free account to keep reading this call
MarginsQ2 FY26 call
Up 0–2%See what Bayer Crop Sci. said on margins — free account, 30 seconds.
CapexQ2 FY26 call
Planned- Bayer CropScience is focusing on expanding its corn seeds portfolio, aiming for a continued doubling as part of its 3-5 year strategic framework.
- Significant new product launches are planned, including major proprietary launch "Plenexos" (insecticide) and other compounds like Xivana Smart targeting fruit and vegetable segments.
- The company is enhancing backward integration for larger compound manufacturing within India to reduce reliance on imports from high currency countries and improve supply chain resilience.
- Go-to-market transformation includes shifting focus toward partnerships and digital channels in less profitable areas to improve operational efficiency and margin per head.
2 more points from Bayer Crop Sci.'s call on capex
Create a free account to keep reading this call
FundraisingQ2 FY26 call
See what Bayer Crop Sci. said on fundraising — free account, 30 seconds.
Order bookQ2 FY26 call
- Supply chain structure and sourcing strategies.
- Margin guidance and cost rationalization.
- Growth outlook and product pipeline.
- Pricing, operating expenses, and market challenges.
Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Fertilizers & Agrochemicals
on management's own guidance
- Dharmaj CropGood growth2
- Anya Polytech &Good growth1
- M B Agro Prod.Good growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Fertilizers & Agrochemicals companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | Anya Polytech & | 20–40% | Up 2%+ | ₹209 Cr | 25.1 |
| 2 | Dharmaj Crop | 20–40% | Up 0–2% | ₹882 Cr | 14.7 |
| 3 | M B Agro Prod. | 20–40% | Flat | ₹7,668 Cr | 49.5 |
| 4 | 20–40% | Flat | ₹6,453 Cr | 32.8 | |
| 5 | 10–20% | Up 2%+ | ₹1,226 Cr | 18.3 | |
| 6 | 10–20% | Flat | ₹51,882 Cr | 27.8 |
Sign up free to see every company in the sector ranking and track Bayer Crop Sci..
Pro shows every company guiding 40%+ revenue growth →Full Fertilizers & Agrochemicals rankingFinancials of Bayer Crop Sci.
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Bayer Crop Sci.
Quarterly Results
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 982 | 1,740 | 1,617 | 955 | 792 | 1,631 | 1,738 | 1,057 | 1,046 | 1,915 | 1,553 | 1,106 | 1,101 |
| Expenses + | 777 | 1,315 | 1,312 | 827 | 695 | 1,317 | 1,554 | 1,037 | 876 | 1,566 | 1,348 | 989 | 898 |
| Operating Profit | 206 | 425 | 305 | 128 | 97 | 314 | 184 | 20 | 171 | 348 | 205 | 117 | 203 |
| OPM % | 21% | 24% | 19% | 13% | 12% | 19% | 11% | 2% | 16% | 18% | 13% | 11% | 18% |
| Other Income + | 24 | 21 | 16 | 15 | 29 | 27 | 24 | 32 | 37 | 19 | 14 | 16 | 47 |
| Interest | 7 | 8 | 4 | 3 | 5 | 4 | 3 | 4 | 6 | 5 | 4 | 5 | 6 |
| Depreciation | 27 | 31 | 12 | 15 | 16 | 22 | 14 | 15 | 34 | 27 | 14 | 15 | 38 |
| Profit before tax | 195 | 406 | 306 | 124 | 105 | 316 | 190 | 34 | 168 | 335 | 200 | 113 | 206 |
| Tax % | 19% | 19% | 27% | 25% | 9% | 20% | 28% | -2% | 15% | 17% | 24% | 15% | 21% |
| Net Profit + | 158 | 328 | 223 | 93 | 96 | 254 | 136 | 34 | 143 | 279 | 153 | 96 | 162 |
| EPS in Rs | 35.27 | 73.09 | 49.60 | 20.72 | 21.36 | 56.56 | 30.33 | 7.61 | 31.89 | 62.01 | 33.98 | 21.29 | 36.07 |
Financials of Bayer Crop Sci.
Profit & Loss
Annual income statement trend
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 3,660 | 2,769 | 2,803 | 2,710 | 3,167 | 3,609 | 4,261 | 4,734 | 5,140 | 5,106 | 5,473 | 5,675 |
| Expenses + | 3,144 | 2,334 | 2,389 | 2,300 | 2,684 | 2,883 | 3,450 | 3,923 | 4,216 | 4,147 | 4,783 | 4,801 |
| Operating Profit | 516 | 435 | 414 | 410 | 483 | 726 | 812 | 812 | 924 | 959 | 691 | 874 |
| OPM % | 14% | 16% | 15% | 15% | 15% | 20% | 19% | 17% | 18% | 19% | 13% | 15% |
| Other Income + | 88 | 82 | 70 | 39 | 51 | -64 | 69 | 112 | 168 | 76 | 118 | 95 |
| Interest | 5 | 10 | 7 | 11 | 10 | 14 | 13 | 13 | 22 | 20 | 17 | 20 |
| Depreciation | 25 | 25 | 29 | 33 | 44 | 65 | 74 | 64 | 80 | 74 | 85 | 94 |
| Profit before tax | 574 | 482 | 448 | 404 | 480 | 583 | 794 | 847 | 990 | 941 | 707 | 855 |
| Tax % | 33% | 35% | 35% | 26% | 30% | 19% | 38% | 24% | 23% | 21% | 20% | 19% |
| Net Profit + | 383 | 315 | 291 | 300 | 337 | 474 | 493 | 645 | 758 | 740 | 568 | 689 |
| EPS in Rs | 104.59 | 89.13 | 82.31 | 87.41 | 98.18 | 105.58 | 109.72 | 143.58 | 168.71 | 164.77 | 126.38 | 153.35 |
| Dividend Payout % | 20% | 19% | 21% | 21% | 18% | 24% | 105% | 104% | 77% | 85% | 99% | 39% |
Financials of Bayer Crop Sci.
Balance Sheet
Capital structure and asset base
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 37 | 35 | 35 | 34 | 34 | 45 | 45 | 45 | 45 | 45 | 45 | 45 |
| Reserves | 1,996 | 1,804 | 2,021 | 1,744 | 2,205 | 2,528 | 2,505 | 2,479 | 2,667 | 2,804 | 2,806 | 2,921 |
| Borrowings + | 0 | 0 | 0 | 0 | 0 | 2 | 26 | 86 | 74 | 47 | 105 | 82 |
| Other Liabilities + | 740 | 597 | 769 | 756 | 1,310 | 1,262 | 1,663 | 1,742 | 1,893 | 1,701 | 2,290 | 2,652 |
| Total Liabilities | 2,773 | 2,437 | 2,825 | 2,535 | 3,549 | 3,836 | 4,239 | 4,353 | 4,679 | 4,597 | 5,246 | 5,699 |
| Fixed Assets + | 322 | 290 | 342 | 334 | 440 | 468 | 425 | 468 | 462 | 414 | 470 | 581 |
| CWIP | 1 | 17 | 24 | 36 | 47 | 56 | 76 | 98 | 109 | 119 | 119 | 5 |
| Investments | 29 | 68 | 50 | 0 | 0 | 41 | 52 | 38 | 41 | 54 | 35 | 57 |
| Other Assets + | 2,422 | 2,062 | 2,410 | 2,164 | 3,062 | 3,270 | 3,686 | 3,749 | 4,066 | 4,010 | 4,622 | 5,056 |
| Total Assets | 2,773 | 2,437 | 2,825 | 2,535 | 3,549 | 3,836 | 4,239 | 4,353 | 4,679 | 4,597 | 5,246 | 5,699 |
Financials of Bayer Crop Sci.
Cash Flows
Operating, investing and financing cash movement
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 200 | 206 | 157 | 121 | 433 | 666 | 687 | 216 | 609 | 952 | 262 | |
| Cash from Investing Activity + | 485 | 16 | -8 | 38 | -113 | -29 | 7 | 64 | 83 | 0 | 86 | |
| Cash from Financing Activity + | -42 | -590 | -73 | -581 | -158 | -148 | -556 | -703 | -613 | -656 | -619 | |
| Net Cash Flow | 644 | -367 | 76 | -421 | 162 | 489 | 138 | -424 | 79 | 296 | -272 | |
| Free Cash Flow | 297 | 170 | 108 | 80 | 378 | 638 | 656 | 168 | 537 | 912 | 222 | |
| CFO/OP | 76% | 86% | 74% | 53% | 132% | 110% | 105% | 59% | 92% | 113% | 61% |
Financials of Bayer Crop Sci.
Ratios
Working capital efficiency and return ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 57 | 53 | 72 | 89 | 81 | 73 | 65 | 77 | 69 | 69 | 63 | 72 |
| Inventory Days | 85 | 169 | 178 | 175 | 294 | 206 | 226 | 235 | 268 | 222 | 319 | 231 |
| Days Payable | 40 | 52 | 67 | 67 | 164 | 101 | 142 | 127 | 129 | 87 | 148 | 134 |
| Cash Conversion Cycle | 102 | 171 | 184 | 197 | 211 | 177 | 149 | 185 | 208 | 204 | 234 | 169 |
| Working Capital Days | 53 | 92 | 104 | 134 | 116 | 77 | 61 | 84 | 86 | 78 | 88 | 60 |
| ROCE % | 31% | 25% | 23% | 22% | 25% | 30% | 31% | 31% | 34% | 34% | 25% | 29% |
Guidance history
How Bayer Crop Sci.'s guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q2 FY26 call → | 0–10% | Up 0–2% | Planned | — | — |
| Q4 FY23 call → | 10–20% | Flat | Planned | — | — |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
7 out of 100 — Cooling
Over the past year its share price has done worse than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | −33.7% | 18% |
| Last 6 months | −29.9% | 8% |
| Last 3 months | −22.7% | 13% |
The price is 52.1% below its all-time high of ₹6,851.5 (2 Aug 2024). Stocks more than 20% below their peak have their score halved, so 13 became 7.
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Bayer Crop Sci.: 0.4 × 18 + 0.4 × 8 + 0.2 × 13 = 13, halved to 7 because the price is more than 20% below its all-time high.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 28 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What Bayer Crop Sci.'s management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Astec Lifescienc (Q2 FY27)
2.3% YoY decline. Key results statement takeaways from Astec Lifescienc's Q2 FY27 results statement — and how it ranks against sector peers.
- Sumitomo Chemical India Ltd (Q2 FY27)
907 crore, down 2% YoY (Q2FY26 revenue was Rs. Key investor presentation takeaways from Sumitomo Chemical India Ltd's Q2 FY27 investor presentation — and how it
- Rallis India (Q2 FY27)
861 Cr. Key investor presentation takeaways from Rallis India's Q2 FY27 investor presentation — and how it ranks against sector peers.
- Bhagiradha Chemicals & Industries Ltd (Q2 FY26)
140.1 crore, up 35% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q2 FY26 investor presentation — and how it ran
